Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2020 2
2021 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I.
Navarrete-Rodríguez EM, Del-Río-Navarro BE, Reyes Noriega N, Berber A, Mérida Palacio V, García-Almaráz R, Ellwood P; GAN Phase I Study group. Navarrete-Rodríguez EM, et al. Among authors: merida palacio v. World Allergy Organ J. 2022 Oct 17;15(11):100710. doi: 10.1016/j.waojou.2022.100710. eCollection 2022 Nov. World Allergy Organ J. 2022. PMID: 36267354 Free PMC article.
Factors associated with allergic rhinitis in children and adolescents from northern Mexico: International Study of Asthma and Allergies in Childhood Phase IIIB.
González-Díaz SN, Del Río-Navarro BE, Pietropaolo-Cienfuegos DR, Escalante-Domínguez AJ, García-Almaraz RG, Mérida-Palacio V, Berber A. González-Díaz SN, et al. Among authors: merida palacio v. Allergy Asthma Proc. 2010 Jul-Aug;31(4):e53-e62. doi: 10.2500/aap.2010.31.3346. Allergy Asthma Proc. 2010. PMID: 20819316 Clinical Trial.
Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations-a cross-sectional study.
Del-Río-Navarro BE, Berber A, Reyes-Noriega N, Navarrete-Rodríguez EM, García-Almaraz R, Ellwood P, Garcia-Marcos L, Saucedo-Ramírez OJ, Mérida-Palacio VJ, Ramos-García BDC, Escalante-Domínguez AJ, Linares-Zapién FJ, Moreno-Gardea HL, Ochoa-López G, Hernández-Mondragón LO, Lozano-Sáenz JS, Sacre-Hazouri JA, Juan-Pineda Á, Sánchez-Coronel MG, Rodríguez-Pérez N, Ambriz-Moreno MJ; GAN Phase I group. Del-Río-Navarro BE, et al. Among authors: merida palacio vj. BMJ Open Respir Res. 2020 Dec;7(1):e000658. doi: 10.1136/bmjresp-2020-000658. BMJ Open Respir Res. 2020. PMID: 33268340 Free PMC article. Clinical Trial.